SCIEX, a global leader in life science analytical technologies, today announced a Co-marketing agreement with Elucidata, a disruptive integrated Omics platform company providing tools for metabolomics data processing.This relationship will uniquely position SCIEX to address the major challenges faced by scientific researchers and allow them to efficiently process all their metabolomics data from a diverse range of workflows. It also allows scientists to interpret these results in a biological context to further advance the fields of target identification and validation, as well as deeply characterize the underlying biology.Under this Agreement, Elucidata and SCIEX will promote Elucidata's integrated Omics platform, called Polly, in conjunction with SCIEX technologies, including TripleTOF, X500R, and QTRAP, as well as Differential Ion Mobility technology.Polly is an end-to-end, vendor-neutral, integrated omics platform that standardizes and streamlines metabolomics data analysis ...
